ISSN 2736-1594
International Journal of Obstetrics and Gynecology ISSN 2736-1594 Vol. 9 (1), pp. 001-005, January, 2021. © International Scholars Journals
Full Length Research Paper
Use of injectable progestogen-only contraceptives at the family planning clinic of the Nnamdi Azikiwe University Teaching Hospital Nnewi, Nigeria
Igwegbe AO and Ugboaja JO
Department of Obstetrics and Gynaecology, Nnamdi Azikiwe University Teaching Hospital, P.M.B. 5025, Nnewi, Anambra State, Nigeria
Accepted 02 November, 2020
Abstract
This retrospective study investigates the use of, complications and discontinuation of injectable progestogen-only contraceptives at the family planning clinic of the Nnamdi Azikiwe University Teaching Hospital Nnewi, Nigeria. 392 (29.1%) of the 1345 new clients chose injectable progestogen-only contraceptives. Among them, 51.5% were spacers while 48.5% were limiters. Also 94.9% of the clients used depot medroxyprogesterone acetate (DMPA) while 5.1% used norethisterone enanthate (NET-EN). Majority of the acceptors belonged to the 30-34 years age bracket (35.7%), were grandmultiparous (63.8%), and had achieved secondary education and above (74.5%). Ninety (23.0%) clients experienced various forms of side effects, of which menstrual irregularity was the commonest (5.6%). The overall discontinuation rate was 6.1%, and the main reason for discontinuation was desirefor pregnancy (4.1%). There was no pregnancy reported during the study period. The likelihood of reporting complications was significantly associated with age (x2= 34.06; p=0.00), and level of education (x2=10.18; p=0.00). The injectable progestogen-only contraceptives are not widely accepted in our centre, and are associated with a low discontinuation rate. There is need to scale up their use in the family planning program in the area.
Key words: Injectables, progestogen-only contraceptives, Nnewi, Nigeria.